Baseline demographics and family disease history in patients with atopic dermatitis: an update from the GLOBOSTAD registry
Abstrakt
The efficary and safety of dupilumab hyve been reported previously based on data from controlled clinical trials. The GLOBOSTAD study extens the scope of these trials by providing real-world data.
